News

Dr Lucio D'Anna discusses the use of pharmacologic and non-pharmacologic approaches, such as left atrial appendage occlusion, to decrease stroke risk in this challenging patient group with Dr Andreas Charidimou, an instructor in neurology at Boston University Medical Center.

Learn about our new resources for involving patients in the decision-making process.

Learn about how PRESTIGE-AF engaged visitors at Imperial Lates using a pop-up escape room.

The PRESTIGE-AF trial has officially recruited 150 patients.

Learn about how members of the PRESTIGE-AF consortium engaged young people from underrepresented groups with stroke research.

The second event in Stroke Alliance Europe's #LifeAfterStroke series, this free webinar will explore intimacy and sex after stroke.

Tune-in! PRESTIGE-AF researchers, Prof Valeria Caso and Dr Fracesco Corea are live streaming (in Italian) at 3pm CET TODAY (04 March) about the PRESTIGE-AF trial in Italy.

After almost 3 months of suspension due to COVID-19, the PRESTIGE-AF Study has resumed recruitment of participants.

Following the successful bid for funding from the European Commission, the PRESTIGE-AF Consortium members came together for the project's kick-off meeting which took place on Wednesday 6th December 2017 and hosted by Imperial College London.

A new 6,9 million euro initiative has been launched with the aim of enhancing more established measures around Stroke prevention in patients with a heart condition called atrial fibrillation (AF) who have previously had a stroke caused by bleeding in the brain (termed intracerebral haemorrhage or ICH).